Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v1-EN
Language French English
Date Updated 2022-04-21 2021-11-11
Drug Identification Number 02397900 02397900
Brand name TEVA-SOLIFENACIN TEVA-SOLIFENACIN
Common or Proper name TEVA-SOLIFENACIN 5MG TAB TEVA-SOLIFENACIN 5MG TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients SOLIFENACIN SUCCINATE SOLIFENACIN SUCCINATE
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code G04BD G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-11-10 2021-11-10
Estimated end date 2022-04-30 2021-12-31
Actual end date 2022-04-20
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments